Developing treatments for prevention of retinopathy of prematurity

References

• Tin W, Milligan DW, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and out-come at one year in babies of less than 28 weeks gestation. Arch. Dis. Child. Fetal Neonatal Ed. 84, F106–F110 (2001).
   PubMed Web of Science ®Google Scholar
• Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ; Australian and New Zealand Neonatal Network. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 115(4), 990–996 (2005).
   PubMed Web of Science ®Google Scholar
• Raghuveer TS, Bloom BT. A paradigm shift in the prevention of retinopathy of prematurity. Neonatology 100(2), 116–129 (2011).
   PubMed Web of Science ®Google Scholar
• Good WV, Hardy RJ, Dobson V et al.; Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 116(1), 15–23 (2005).
   PubMed Web of Science ®Google Scholar
• Fanaroff AA, Stoll BJ, Wright LL et al.; NICHD Neonatal Research Network. Trends in neonatal morbidity and mortality for very low birthweight infants. Am. J. Obstet. Gynecol. 196(2), 147.e1–147.e8 (2007).
   PubMed Web of Science ®Google Scholar
• Austeng D, Källen KB, Ewald UW, Jakobsson PG, Holmström GE. Incidence of retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden. Arch. Ophthalmol. 127(10), 1315–1319 (2009).
   PubMedGoogle Scholar
• Lad EM, Hernandez-Boussard T, Morton JM, Moshfeghi DM. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am. J. Ophthalmol. 148(3), 451–458 (2009).
   PubMed Web of Science ®Google Scholar
• Hughes S, Yang H, Chan-Ling T. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest. Ophthalmol. Vis. Sci. 41(5), 1217–1228 (2000).
   PubMed Web of Science ®Google Scholar
• Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch. Ophthalmol. 114(10), 1219–1228 (1996).
   PubMedGoogle Scholar
• Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 10(2), 133–140 (2007).
   PubMedGoogle Scholar
• Saugstad OD, Aune D. In search of the optimal oxygen saturation for extremely low birth weight infants: a systematic review and meta-analysis. Neonatology 100(1), 1–8 (2011).
   PubMed Web of Science ®Google Scholar
• Rivera JC, Sapieha P, Joyal JS et al. Understanding retinopathy of prematurity: update on pathogenesis. Neonatology 100(4), 343–353 (2011).
   PubMed Web of Science ®Google Scholar
• Frank L, Sosenko IR. Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr. Res. 29(3), 292–296 (1991).
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 71(2), 226–235 (2006).
   PubMed Web of Science ®Google Scholar
• Gu X, El Remessy AB, Brooks SE, Al Shabrawey M, Tsai NT, Caldwell RB. Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am. J. Physiol. Cell Physiol. 285, C546–C554 (2003).
   PubMed Web of Science ®Google Scholar
• Sahgal N, Davis JM, Robbins C et al. Localization and activity of recombinant human CuZn superoxide dismutase after intratracheal administration. Am. J. Physiol. 271(2 Pt 1), L230–L235 (1996).
   PubMedGoogle Scholar
• Rosenfeld WN, Davis JM, Parton L et al. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 97(6 Pt 1), 811–817 (1996).
   PubMed Web of Science ®Google Scholar
• Saugstad OD, Speer CP, Halliday HL. Oxygen saturation in immature babies: revisited with updated recommendations. Neonatology 100(3), 217–218 (2011).
   PubMed Web of Science ®Google Scholar
• Chow LC, Wright KW, Sola A; CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 111(2), 339–345 (2003).
   PubMed Web of Science ®Google Scholar
• Raju TN, Langenberg P, Bhutani V, Quinn GE. Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J. Pediatr. 131(6), 844–850 (1997).
   PubMed Web of Science ®Google Scholar
• Johnson L, Quinn GE, Abbasi S et al. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J. Pediatr. 114(5), 827–838 (1989).
   PubMed Web of Science ®Google Scholar
• Phelps DL, Lakatos L, Watts JL. d-penicillamine for preventing retinopathy of prematurity in preterm infants. Cochrane Database Syst. Rev. (1), CD001073 (2001).
   PubMedGoogle Scholar
• Mantagos IS, Vanderveen DK, Smith LE. Emerging treatments for retinopathy of prematurity. Semin. Ophthalmol. 24(2), 82–86 (2009).
   PubMed Web of Science ®Google Scholar
• Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W; North American Recombinant Human CuZnSOD Study Group. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 111(3), 469–476 (2003).
   PubMed Web of Science ®Google Scholar
• Parad RB, Allred EN, Rosenfeld WN, Davis JM. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human cu/zn superoxide dismutase. Neonatology 102(2), 139–144 (2012).
   PubMed Web of Science ®Google Scholar
• Carlo WA, Finer NN, Walsh MC et al. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network; Target ranges of oxygen saturation in extremely preterm infants. N. Engl. J. Med. 362(21);1959–1969 (2010).
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N. Engl. J. Med. 364(7), 603–615 (2011).
   PubMed Web of Science ®Google Scholar